BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Visual restoration : validations of the photovoltaic retinal prost
 hesis and of optogenetic therapy in non-human primates
DTSTART:20171121T121500
DTEND:20171121T131500
DTSTAMP:20260506T080520Z
UID:6d13d660bb084d8ffdb719698e3f16c8a1754d364c4ae4a987dcc944
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr Serge Picaud\, Institut de la Vision\, Paris\, France\nBli
 ndness can result from the loss of photoreceptors in retinal dystrophies o
 r age-related macular degeneration. Electrical activation of the residual 
 retinal neurons can restore some visual function in blind patients. Howeve
 r\, the perception provided by current retinal prostheses does not allow f
 ace recognition or autonomous motion in an unknown environment. To reach t
 hese goals\, Serge Picaud and his team have assessed from a functional poi
 nt of view the new photovoltaic retinal implants and  optogenetic therapy
 . Both strategies were validated on non-human primates to speed up their t
 ranslation to clinical trials. The talk will present these recent and unpu
 blished results for restoring high quality vision.  \n\nBio:\nSerge Picau
 d is a Principal Investigator at the  Paris Vision Institute.  He holds 
 a PhD in Neuroscience from the University of Marseille and learned retinal
  pathophysiology and electrophysiology at the Max-Planck Institute for Bra
 in Research (Frankfurt\, Germany) and at UC Berkeley\, respectively.  Ser
 ge has worked on photoreceptor physiology prior to studying their pharmaco
 logical neuroprotection to finally investigate strategies for their substi
 tution.\n\n\n 
LOCATION:Campus Biotech H8 Auditorium http://cnp.epfl.ch/files/content/sit
 es/cnp/files/Seminars/PlanSallesCampusBiotechH8-01.pdf
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR